-
MLN8237 (Alisertib): Precision Targeting of Aurora A in Canc
2026-08-06
This thought-leadership article explores the mechanistic, translational, and strategic landscape of MLN8237 (Alisertib) as a selective Aurora A kinase inhibitor, offering practical guidance to cancer researchers. We synthesize recent clinical insights, experimental protocols, and competitive differentiation, with a focus on retinoblastoma and advanced tumor models.
-
Norovirus Utilizes NINJ1 for Selective NS1 Secretion via Cel
2026-08-05
The referenced study demonstrates that murine norovirus (MNoV) co-opts the host protein NINJ1 to enable selective secretion of its NS1 protein through regulated plasma membrane rupture. By uncovering a specific, caspase-3–dependent, unconventional secretion mechanism, these findings redefine the interface between viral immune evasion and programmed cell death, offering new insights for infection biology and cell death research.
-
Gap19: Elevating Selective Connexin 43 Hemichannel Blockade
2026-08-05
This thought-leadership article explores the mechanistic and translational significance of Gap19, a highly selective connexin 43 hemichannel blocker. We synthesize recent advances in neuroglial modulation, ischemia neuroprotection, and immune signaling—highlighting how Gap19 enables new frontiers in research on stroke, inflammation, and macrophage polarization. Strategic guidance is provided for experimental design and protocol optimization, while a forward-looking outlook identifies emerging translational opportunities. The discussion references foundational and recent literature, positioning this article as an essential bridge from bench to bedside for translational scientists.
-
Gap26: Redefining Gap Junction Targeting in Translational Re
2026-08-04
This article explores the mechanistic and translational impact of Gap26, a connexin 43 mimetic peptide, as a strategic asset for researchers studying intercellular signaling. Drawing on new evidence from breakthrough cancer pain (BTcP) models and recent literature, it provides experimental guidance, discusses competitive positioning, and frames future directions for leveraging APExBIO's Gap26 in disease modeling.
-
Thermal Shift Assays for Ligand Discovery in Bacterial Senso
2026-08-04
This review highlights the application of thermal shift assays (TSAs) for identifying ligands that interact with bacterial sensor proteins, focusing on advances in ligand-binding domain (LBD) analysis. The paper outlines methodological refinements, discusses assay reliability, and addresses implications for high-throughput screening and functional annotation of bacterial receptors.
-
HDAC Inhibition Reverses EBV-Induced Plasticity in NPC Cells
2026-08-03
The reference study elucidates how Epstein-Barr virus (EBV) induces dedifferentiation and stem-like plasticity in nasopharyngeal carcinoma (NPC) through histone deacetylase (HDAC)-mediated repression of CEBPA. By demonstrating that HDAC inhibitors can restore differentiation and reduce tumor cell plasticity in preclinical models, the paper advances the mechanistic rationale for epigenetic differentiation therapy in solid tumors.
-
Patient-Specific iPSC Platforms for Ultrarare Disease Trials
2026-08-03
This study introduces a patient-derived iPSC-based screening platform to evaluate drug efficacy and safety in ultrarare metabolic disorders, exemplified by Leigh-like syndrome. The platform enables personalized prescreening to inform clinical trial enrollment, addressing limitations of conventional "trial and error" approaches in rare disease therapeutics.
-
Camptothecin: Precision Topoisomerase I Inhibitor for DNA Da
2026-08-02
Camptothecin empowers researchers to dissect DNA damage, apoptosis, and adaptive mutagenesis with high specificity by targeting topoisomerase I. This article reveals advanced protocols, troubleshooting tips, and strategic applications for leveraging Camptothecin in next-generation cancer and genome stability research.
-
Universal nPEC Method for Dual-Loaded Liposome Efficiency An
2026-08-01
This study establishes nanoparticle exclusion chromatography (nPEC) as a robust, universally applicable method for accurately determining the encapsulation efficiency of dual-loaded liposomes with distinct drug properties. Its streamlined, no-preparation workflow advances quality assessment in nanocarrier-based combination therapies, facilitating reproducible research and optimized co-delivery strategies.
-
Light-Inducible RNA Switches for Precise Gene Therapy Contro
2026-07-31
This study presents a rationally engineered light-inducible RNA-releasing protein (LIRP) system that enables spatiotemporal control of mRNA translation in mammalian cells. The work demonstrates the system’s versatility across multiple tissues and disease models, offering a significant advance for translational regulation and optogenetic gene therapy strategies.
-
Levofloxacin: Synthetic Fluoroquinolone Antibiotic Applicati
2026-07-31
Levofloxacin is a synthetic fluoroquinolone antibiotic that inhibits bacterial DNA gyrase, halting DNA replication and conferring broad-spectrum antibacterial activity. Its unique properties enable precise assays in osteoblast and chondrocyte biology, as well as antimicrobial research. APExBIO supplies rigorously characterized Levofloxacin for advanced research workflows.
-
3-Bromopyruvate Restores Cetuximab Sensitivity via Ferroptos
2026-07-30
This study demonstrates that co-treatment with 3-Bromopyruvate and cetuximab effectively overcomes resistance in colorectal cancer cells by activating autophagy-dependent ferroptosis. The findings highlight key signaling mechanisms and suggest practical strategies for targeting drug-resistant colorectal cancer.
-
Gap26 Connexin 43 Mimetic Peptide: Mitochondrial Transfer an
2026-07-30
Explore how Gap26, a connexin 43 mimetic peptide, enables precise modulation of intercellular mitochondrial transfer through gap junctions—revealing new opportunities for liver protection and advanced cell signaling research.
-
DAPI Solution (1 mg/mL): Applied Workflows for Nuclear Visua
2026-07-29
APExBIO’s DAPI Solution (1 mg/mL) empowers precise, high-contrast nuclear visualization in fixed, apoptotic, and senescent cells—crucial for viability, apoptosis, and DNA content assays. This guide distills experimental protocols, troubleshooting strategies, and workflow optimizations grounded in the latest macrophage-NP cell senescence research.
-
TMEM16F in Kupffer Cells Regulates Liver Inflammation in Lis
2026-07-29
This study reveals that TMEM16F, a calcium-activated lipid scramblase, is essential in Kupffer cells for protecting the liver against Listeria monocytogenes by preserving plasma membrane integrity and regulating inflammatory responses. These findings clarify cell-specific host defense mechanisms and inform targeted approaches to studying inflammatory liver injury.